CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,822,941 | +12.3% | 994,161 | -17.5% | 9.80% | +13.4% |
| Q2 2023 | $13,195,298 | +10.5% | 1,205,050 | -12.0% | 8.65% | -13.2% |
| Q1 2023 | $11,945,763 | +15.2% | 1,369,927 | -17.1% | 9.96% | +11.1% |
| Q4 2022 | $10,367,414 | +27.4% | 1,653,495 | -28.9% | 8.97% | +22.1% |
| Q3 2022 | $8,140,000 | +6.5% | 2,325,833 | -10.2% | 7.34% | +12.8% |
| Q2 2022 | $7,640,000 | +76.9% | 2,589,679 | +86.5% | 6.51% | +62.3% |
| Q1 2022 | $4,318,000 | +4.3% | 1,388,505 | +13.4% | 4.01% | +11.0% |
| Q4 2021 | $4,140,000 | – | 1,224,968 | – | 3.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |